CoChat

Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?

Open access
Macías-Rodríguez, Ricardo U., Inzaugarat, María Eugenia, Ruiz-Margáin, Astrid, Nelson, Leonard J., Trautwein, Christian, Cubero, Francisco Javier · 2020 · International Journal of Molecular Sciences
Cited by 115

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Ferroptosis has emerged as a new type of cell death in different pathological conditions, including neurological and kidney diseases and, especially, in different types of cancer. The hallmark of this regulated cell death is the presence of iron-driven lipid peroxidation; the activation of key genes related to this process such as glutathione peroxidase-4 (gpx4), acyl-CoA synthetase long-chain family member-4 (acsl4), carbonyl reductase [NADPH] 3 (cbr3), and prostaglandin peroxidase synthase-2 (ptgs2); and morphological changes including shrunken and electron-dense mitochondria. Iron overload in the liver has long been recognized as both a major trigger of liver damage in different diseases, and it is also associated with liver fibrosis. New evidence suggests that ferroptosis might be a novel type of non-apoptotic cell death in several liver diseases including non-alcoholic steatohepatitis (NASH), alcoholic liver disease (ALD), drug-induced liver injury (DILI), viral hepatitis, and hemochromatosis. The interaction between iron-related lipid peroxidation, cellular stress signals, and antioxidant systems plays a pivotal role in the development of this novel type of cell death. In addition, integrated responses from lipidic mediators together with free iron from iron-containing enzymes are essential to understanding this process. The presence of ferroptosis and the exact mechanisms leading to this non-apoptotic type of cell death in the liver remain scarcely elucidated. Recognizing ferroptosis as a novel type of cell death in the liver could lead to the understanding of the complex interaction between different types of cell death, their role in progression of liver fibrosis, the development of new biomarkers, as well as the use of modulators of ferroptosis, allowing improved theranostic approaches in the clinic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21051651

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 140

  1. Green, 2002, AGA technical review on the evaluation of liver chemistry tests, Gastroenterology, 123, 1367, 10.1053/gast.2002.36061 · DOI · Paper page
  2. Rinella, 2015, Nonalcoholic fatty liver disease: A systematic review, JAMA, 313, 2263, 10.1001/jama.2015.5370 · DOI · Paper page
  3. Moriyama, 2005, Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy, Liver Int., 25, 85, 10.1111/j.1478-3231.2005.01028.x · doi:10.1111/j.1478-3231.2005.01028.x
  4. Miyake, 2006, Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis, Aliment. Pharmacol. Ther., 24, 1197, 10.1111/j.1365-2036.2006.03113.x · DOI
  5. Eguchi, 2014, Biomarkers of liver cell death, J. Hepatol., 60, 1063, 10.1016/j.jhep.2013.12.026 · DOI · Paper page
  6. Luedde, 2014, Cell death and cell death responses in liver disease: Mechanisms and clinical relevance, Gastroenterology, 147, 765, 10.1053/j.gastro.2014.07.018 · DOI · Paper page
  7. Wang, 2015, Molecular mechanisms of hepatic apoptosis regulated by nuclear factors, Cell. Signal., 27, 729, 10.1016/j.cellsig.2014.11.038 · DOI
  8. Dixon, 2012, Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
  9. Mehta, 2019, Iron and liver fibrosis: Mechanistic and clinical aspects, World J. Gastroenterol., 25, 521, 10.3748/wjg.v25.i5.521 · DOI · Paper page
  10. Pietrangelo, 2009, Iron in NASH, chronic liver diseases and HCC: How much iron is too much?, J. Hepatol., 50, 249, 10.1016/j.jhep.2008.11.011 · DOI
  11. Li, 2015, The Role of Oxidative Stress and Antioxidants in Liver Diseases, Int. J. Mol. Sci., 16, 26087, 10.3390/ijms161125942 · DOI · Paper page
  12. Man, 2016, Converging roles of caspases in inflammasome activation, cell death and innate immunity, Nat. Rev. Immunol., 16, 7, 10.1038/nri.2015.7 · DOI · Paper page
  13. Hotchkiss, 2009, Cell Death, N. Engl. J. Med., 361, 1570, 10.1056/NEJMra0901217 · DOI · Paper page
  14. Rautou, 2008, Acute Liver Cell Damage in Patients With Anorexia Nervosa: A Possible Role of Starvation-Induced Hepatocyte Autophagy, Gastroenterology, 135, 840, 10.1053/j.gastro.2008.05.055 · DOI · Paper page
  15. Lamkanfi, 2016, Pyroptosis, Curr. Biol., 26, R568, 10.1016/j.cub.2016.02.019 · DOI · Paper page
  16. Wallach, 2016, Programmed necrosis in inflammation: Toward identification of the effector molecules, Science, 352, aaf2154, 10.1126/science.aaf2154 · DOI · Paper page
  17. Mizushima, 2011, Autophagy: Renovation of cells and tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026 · DOI · Paper page
  18. Ueno, 2017, Autophagy in the liver: Functions in health and disease, Nat. Rev. Gastroenterol. Hepatol., 14, 170, 10.1038/nrgastro.2016.185 · DOI · Paper page
  19. Cadwell, 2016, Crosstalk between autophagy and inflammatory signalling pathways: Balancing defence and homeostasis, Nat. Rev. Immunol., 16, 661, 10.1038/nri.2016.100 · DOI · Paper page
  20. Denton, 2019, Autophagy-dependent cell death, Cell Death Differ., 26, 605, 10.1038/s41418-018-0252-y · DOI · Paper page
  21. Guicciardi, 2005, Apoptosis: A mechanism of acute and chronic liver injury, Gut, 54, 1024, 10.1136/gut.2004.053850 · DOI · Paper page
  22. Wang, 2014, Molecular mechanisms of hepatic apoptosis, Cell Death Dis., 5, e996, 10.1038/cddis.2013.499 · DOI · Paper page
  23. Taylor, 2008, Apoptosis: Controlled demolition at the cellular level, Nat. Rev. Mol. Cell Biol., 9, 231, 10.1038/nrm2312 · DOI · Paper page
  24. Canbay, 2003, Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression, Hepatology, 38, 1188, 10.1053/jhep.2003.50472 · DOI · Paper page
  25. Green, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309 · DOI · Paper page
  26. Bao, 2007, Apoptosome: A platform for the activation of initiator caspases, Cell Death Differ., 14, 56, 10.1038/sj.cdd.4402028 · DOI · Paper page
  27. Ow, 2008, Cytochrome c: Functions beyond respiration, Nat. Rev. Mol. Cell Biol., 9, 532, 10.1038/nrm2434 · DOI · Paper page
  28. Wilson, 2009, Death receptor signal transducers: Nodes of coordination in immune signaling networks, Nat. Immunol., 10, 348, 10.1038/ni.1714 · DOI · Paper page
  29. Bordon, 2016, Cell death and immunity: Gasdermins: The hole picture emerges, Nat. Rev. Immunol., 16, 401, 10.1038/nri.2016.76 · doi:10.1038/nri.2016.76
  30. Thome, 1997, Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature, 386, 517, 10.1038/386517a0 · DOI · Paper page
  31. Galluzzi, 2017, Necroptosis: Mechanisms and Relevance to Disease, Annu. Rev. Pathol. Mech. Dis., 12, 103, 10.1146/annurev-pathol-052016-100247 · DOI · Paper page
  32. Krysko, 2008, Apoptosis and necrosis: Detection, discrimination and phagocytosis, Methods, 44, 205, 10.1016/j.ymeth.2007.12.001 · DOI · Paper page
  33. Tomaipitinca, L., Mandatori, S., Mancinelli, R., Giulitti, F., Petrungaro, S., Moresi, V., Facchiano, A., Ziparo, E., Gaudio, E., and Giampietri, C. (2019). The Role of Autophagy in Liver Epithelial Cells and Its Impact on Systemic Homeostasis. Nutrients, 11. · DOI
  34. Mizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038/nature06639 · DOI · Paper page
  35. Yang, 2007, Permeases recycle amino acids resulting from autophagy, Autophagy, 3, 149, 10.4161/auto.3631 · DOI
  36. Fleming, 2012, Iron overload in human disease, N. Engl. J. Med., 366, 348, 10.1056/NEJMra1004967 · DOI · Paper page
  37. Meynard, 2014, The liver: Conductor of systemic iron balance, Blood, 123, 168, 10.1182/blood-2013-06-427757 · DOI · Paper page
  38. Zhao, 2013, Iron regulation by hepcidin, J. Clin. Invest., 123, 2337, 10.1172/JCI67225 · DOI · Paper page
  39. Wang, 2019, Liver iron sensing and body iron homeostasis, Blood, 133, 18, 10.1182/blood-2018-06-815894 · DOI · Paper page
  40. Gaschler, 2017, Lipid peroxidation in cell death, Biochem. Biophys. Res. Commun., 482, 419, 10.1016/j.bbrc.2016.10.086 · DOI · Paper page
  41. Dalleau, 2013, Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance, Cell Death Differ., 20, 1615, 10.1038/cdd.2013.138 · DOI · Paper page
  42. Feng, H., and Stockwell, B.R. (2018). Unsolved mysteries: How does lipid peroxidation cause ferroptosis?. PLoS Biol., 16. · DOI · Paper page
  43. Shimada, 2016, Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity, Cell Chem. Biol., 23, 225, 10.1016/j.chembiol.2015.11.016 · DOI · Paper page
  44. Sato, 1999, Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins, J. Biol. Chem., 274, 11455, 10.1074/jbc.274.17.11455 · DOI · Paper page
  45. Xu, 2013, Iron and copper in mitochondrial diseases, Cell Metab., 17, 319, 10.1016/j.cmet.2013.02.004 · DOI · Paper page
  46. Beard, 2001, Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning, J. Nutr., 131, 568S, 10.1093/jn/131.2.568S · DOI · Paper page
  47. Wang, 2017, Characterization of ferroptosis in murine models of hemochromatosis, Hepatology, 66, 449, 10.1002/hep.29117 · DOI · Paper page
  48. Lee, 2018, Ferroptosis-induced endoplasmic reticulum stress: Cross-talk between ferroptosis and apoptosis, Mol. Cancer Res., 16, 1073, 10.1158/1541-7786.MCR-18-0055 · DOI · Paper page
  49. Amri, 1994, Fatty acids as signal transducing molecules: Involvement in the differentiation of preadipose to adipose cells, J. Lipid Res., 35, 930, 10.1016/S0022-2275(20)39187-2 · DOI · Paper page
  50. De Carvalho, C.C.C.R., and Caramujo, M.J. (2018). The various roles of fatty acids. Molecules, 23. · DOI · Paper page
  51. Sellmayer, 1996, Effects of different polunsaturated fatty acids on growth-related early gene expression and cell growth, Lipids, 31, S37, 10.1007/BF02637048 · doi:10.1007/bf02637048
  52. Brash, 2001, Arachidonic acid as a bioactive molecule, J. Clin. Invest., 107, 1339, 10.1172/JCI13210 · DOI · Paper page
  53. Tang, 1996, Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis, Proc. Natl. Acad. Sci. USA., 93, 5241, 10.1073/pnas.93.11.5241 · DOI · Paper page
  54. Magtanong, 2016, Emerging roles for lipids in non-apoptotic cell death, Cell Death Differ., 23, 1099, 10.1038/cdd.2016.25 · DOI · Paper page
  55. Fullerton, 2014, Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2, Nat. Med., 20, 518, 10.1038/nm.3516 · DOI · Paper page
  56. McMahon, 2001, The Cap’n’Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, Cancer Res., 61, 3299
  57. Leone, 2015, Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway, Free Radic. Biol. Med., 89, 287, 10.1016/j.freeradbiomed.2015.07.155 · DOI
  58. Kang, 2004, Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes, Proc. Natl. Acad. Sci. USA, 101, 2046, 10.1073/pnas.0308347100 · DOI · Paper page
  59. Long, 2017, β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling, Cell Chem. Biol., 24, 944, 10.1016/j.chembiol.2017.06.009 · DOI
  60. Takaya, 2012, Validation of the multiple sensor mechanism of the Keap1-Nrf2 system, Free Radic. Biol. Med., 53, 817, 10.1016/j.freeradbiomed.2012.06.023 · DOI · Paper page
  61. Chiu, 2014, Special issue on “Oxidative stress and mitochondrial alterations in aging and disease”, Free Radic. Res., 48, 967, 10.3109/10715762.2014.948536 · DOI
  62. Kim, 2009, 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: Possible roles of iron and ROS, Carcinogenesis, 30, 645, 10.1093/carcin/bgp012 · DOI
  63. Suzuki, 2018, An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment, Antioxid. Redox Signal., 29, 1746, 10.1089/ars.2017.7358 · DOI
  64. Kawatani, 2011, Nrf2 and selenoproteins are essential for maintaining oxidative homeostasis in erythrocytes and protecting against hemolytic anemia, Blood, 117, 986, 10.1182/blood-2010-05-285817 · DOI
  65. Liu, 2013, Pirin is an iron-dependent redox regulator of NF-κB, Proc. Natl. Acad. Sci. USA, 110, 9722, 10.1073/pnas.1221743110 · DOI · Paper page
  66. Nakajima, 2013, Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein response, Free Radic. Biol. Med., 65, 162, 10.1016/j.freeradbiomed.2013.06.020 · DOI · Paper page
  67. Kalinowski, 2012, Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: Long-lived NO that is trafficked by interacting proteins, J. Biol. Chem., 287, 6960, 10.1074/jbc.R111.329847 · DOI
  68. Richardson, 2008, The nitric oxide-iron interplay in mammalian cells: Transport and storage of dinitrosyl iron complexes, Biochim. Biophys. Acta, 1780, 638, 10.1016/j.bbagen.2007.12.009 · DOI
  69. Ding, 2000, Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator, Proc. Natl. Acad. Sci. USA, 97, 5146, 10.1073/pnas.97.10.5146 · DOI · Paper page
  70. Osler, 1899, Clinical Remarks on Hypertrophic Cirrhosis of the Liver with Bronzing of the Skin: Haemochromatosis, Br. Med. J., 2, 1595, 10.1136/bmj.2.2032.1595 · doi:10.1136/bmj.2.2032.1595
  71. Anderson, 2013, Iron homeostasis in the liver, Compr. Physiol., 3, 315, 10.1002/cphy.c120016 · DOI · Paper page
  72. Niederau, 1996, Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, 110, 1107, 10.1053/gast.1996.v110.pm8613000 · DOI · Paper page
  73. Fracanzani, 1995, Portal hypertension and iron depletion in patients with genetic hemochromatosis, Hepatology, 22, 1127, 10.1002/hep.1840220417 · DOI
  74. Cooksey, 2004, Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis, Endocrinology, 145, 5305, 10.1210/en.2004-0392 · DOI · Paper page
  75. Castro, 2002, Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function, Diabetes, 51, 1000, 10.2337/diabetes.51.4.1000 · DOI · Paper page
  76. Valenti, 2011, Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study, QJM, 104, 141, 10.1093/qjmed/hcq170 · DOI
  77. Simcox, 2013, Iron and diabetes risk, Cell Metab., 17, 329, 10.1016/j.cmet.2013.02.007 · DOI · Paper page
  78. Deugnier, 2017, Dysmetabolic iron overload syndrome (DIOS), Presse Med., 46, e306, 10.1016/j.lpm.2017.05.036 · DOI
  79. Turlin, 2001, Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients, Am. J. Clin. Pathol., 116, 263, 10.1309/WWNE-KW2C-4KTW-PTJ5 · DOI · Paper page
  80. Marmur, J., Beshara, S., Eggertsen, G., Onelöv, L., Albiin, N., Danielsson, O., Hultcrantz, R., and Stål, P. (2018). Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease. BMC Gastroenterol., 18. · DOI
  81. Kowdley, 2012, NASH Clinical Research Network Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 55, 77, 10.1002/hep.24706 · DOI · Paper page
  82. Valenti, 2010, HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease, Gastroenterology, 138, 905, 10.1053/j.gastro.2009.11.013 · DOI · Paper page
  83. Fracanzani, 2011, Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity, J. Hepatol., 54, 1244, 10.1016/j.jhep.2010.09.037 · DOI
  84. Fargion, 2001, Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis, Am. J. Gastroenterol., 96, 2448, 10.1111/j.1572-0241.2001.04052.x · doi:10.1111/j.1572-0241.2001.04052.x · Paper page
  85. Manousou, 2011, Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients, Liver Int., 31, 730, 10.1111/j.1478-3231.2011.02488.x · DOI · Paper page
  86. Hoki, 2015, Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis, Hepatology, 62, 751, 10.1002/hep.27774 · DOI
  87. Dongiovanni, 2011, Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target, J. Hepatol., 55, 920, 10.1016/j.jhep.2011.05.008 · DOI · Paper page
  88. Beaton, M.D., Chakrabarti, S., Levstik, M., Speechley, M., Marotta, P., and Adams, P. (2013). Phase II clinical trial of phlebotomy for non-Alcoholic fatty liver disease. Aliment. Pharmacol. Ther. · DOI
  89. Schafer, 2006, Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression, J. Biol. Chem., 281, 22974, 10.1074/jbc.M602098200 · DOI · Paper page
  90. Klein, 2007, Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol, Hepatology, 46, 1979, 10.1002/hep.21895 · DOI · Paper page
  91. Eng, 2005, V Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis, Liver Int., 25, 513, 10.1111/j.1478-3231.2005.01004.x · DOI
  92. Batista, 2012, Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls, Eur. J. Gastroenterol. Hepatol., 24, 1158, 10.1097/MEG.0b013e328355cfd0 · DOI
  93. Hultcrantz, 1993, Iron increases ethanol toxicity in rat liver, J. Hepatol., 17, 108, 10.1016/S0168-8278(05)80530-6 · DOI
  94. Tsukamoto, 1995, Experimental liver cirrhosis induced by alcohol and iron, J. Clin. Invest., 96, 620, 10.1172/JCI118077 · DOI · Paper page
  95. Fletcher, 2002, Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis, Gastroenterology, 122, 281, 10.1053/gast.2002.30992 · DOI · Paper page
  96. Pietrangelo, 2003, Iron-induced oxidant stress in alcoholic liver fibrogenesis, Alcohol, 30, 121, 10.1016/S0741-8329(03)00126-5 · DOI
  97. Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology, 35, 635, 10.1053/jhep.2002.31782 · DOI · Paper page
  98. Christidis, 2000, Liver iron is predictive of death in alcoholic cirrhosis: A multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: A prospective follow up study, Gut, 46, 277, 10.1136/gut.46.2.277 · DOI · Paper page
  99. Ma, L., Zou, T., Yuan, Y., Lv, J., Dong, X., Yang, G., Zhu, Y., Luo, J., Zhang, Z., and Yang, J. (2014). Duodenal ferroportin is up-regulated in patients with chronic hepatitis C. PLoS One, 9. · DOI
  100. Fujita, 2007, Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients, Free Radic. Biol. Med., 42, 353, 10.1016/j.freeradbiomed.2006.11.001 · DOI
  101. Lambrecht, 2011, HALT-C Trial Group Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C, Gastroenterology, 140, 1490, 10.1053/j.gastro.2011.01.053 · DOI
  102. Guyader, 2007, Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C, J. Hepatol., 46, 587, 10.1016/j.jhep.2006.09.021 · DOI
  103. Martin, 2013, Identification of transferrin receptor 1 as a hepatitis C virus entry factor, Proc. Natl. Acad. Sci. USA, 110, 10777, 10.1073/pnas.1301764110 · doi:10.1073/pnas.1301764110
  104. Theurl, 2004, Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3, J. Infect. Dis., 190, 819, 10.1086/422261 · DOI · Paper page
  105. Li, 2016, Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications, J. Hepatol., 64, S32, 10.1016/j.jhep.2016.02.011 · DOI
  106. Ryan, 2012, Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C, Hepatology, 56, 492, 10.1002/hep.25666 · DOI · Paper page
  107. Ferrara, 2009, Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C, Am. J. Gastroenterol., 104, 605
  108. Lange, 2012, Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy, Hepatology, 55, 1038, 10.1002/hep.24787 · DOI
  109. Andrade, 2017, Drug-induced liver injury: Recent advances in diagnosis and risk assessment, Gut, 66, 1154, 10.1136/gutjnl-2016-313369 · DOI · Paper page
  110. Lee, 2017, Acetaminophen (APAP) hepatotoxicity-Isn’t it time for APAP to go away?, J. Hepatol., 67, 1324, 10.1016/j.jhep.2017.07.005 · DOI · Paper page
  111. Du, 2016, Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential, Redox Biol., 10, 148, 10.1016/j.redox.2016.10.001 · DOI · Paper page
  112. Heidari, 2016, Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver, Toxicol. Res., 32, 133, 10.5487/TR.2016.32.2.133 · DOI
  113. Ramappa, 2013, Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management, J. Clin. Exp. Hepatol., 3, 37, 10.1016/j.jceh.2012.12.001 · DOI · Paper page
  114. Laarakkers, 2012, Acute acetaminophen intoxication leads to hepatic iron loading by decreased hepcidin synthesis, Toxicol. Sci., 129, 225, 10.1093/toxsci/kfs176 · DOI
  115. Nahon, 2008, Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis, Gastroenterology, 134, 102, 10.1053/j.gastro.2007.10.038 · DOI · Paper page
  116. Hellerbrand, 2003, HFE C282Y heterozygosity in hepatocellular carcinoma: Evidence for an increased prevalence, Clin. Gastroenterol. Hepatol., 1, 279, 10.1016/S1542-3565(03)00132-0 · DOI
  117. Louandre, 2013, Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib, Int. J. Cancer, 133, 1732, 10.1002/ijc.28159 · DOI · Paper page
  118. Lachaier, 2014, Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors, Anticancer Res., 34, 6417
  119. Okuma, 2018, Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations, J. Cancer Res. Clin. Oncol., 144, 1601, 10.1007/s00432-018-2681-x · DOI
  120. Raja, 1994, Intestinal iron absorption studies in mouse models of iron-overload, Br. J. Haematol., 86, 156, 10.1111/j.1365-2141.1994.tb03267.x · doi:10.1111/j.1365-2141.1994.tb03267.x
  121. Fleming, R.E., Feng, Q., and Britton, R.S. (2011). Knockout Mouse Models of Iron Homeostasis. Annu. Rev. Nutr. · DOI
  122. Masaratana, 2011, Iron absorption in hepcidin1 knockout mice, Br. J. Nutr., 105, 1583, 10.1017/S0007114510005507 · DOI
  123. Lunova, 2014, Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload, J. Hepatol., 61, 633, 10.1016/j.jhep.2014.04.034 · DOI
  124. Kalaitzakis, 2013, Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis, Scand. J. Gastroenterol., 48, 577, 10.3109/00365521.2013.777468 · DOI
  125. Les, 2010, Quality of life in cirrhosis is related to potentially treatable factors, Eur. J. Gastroenterol. Hepatol., 22, 221, 10.1097/MEG.0b013e3283319975 · DOI · Paper page
  126. Qamar, 2009, Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis, Clin. Gastroenterol. Hepatol., 7, 689, 10.1016/j.cgh.2009.02.021 · DOI · Paper page
  127. Cirera, 1997, Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension, Dig. Dis. Sci., 42, 1697, 10.1023/A:1018861415259 · DOI
  128. Zhang, 2019, Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model, Cell Chem. Biol., 26, 623, 10.1016/j.chembiol.2019.01.008 · DOI · Paper page
  129. Sato, 2018, The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells, Sci. Rep., 8, 1
  130. Sui, 2018, RSL3 drives ferroptosis through GPX4 inactivation and ros production in colorectal cancer, Front. Pharmacol., 9, 1371, 10.3389/fphar.2018.01371 · DOI · Paper page
  131. Bordin, 2019, Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε, FEBS Lett., 594, 611
  132. Miotto, 2020, Insight into the mechanism of ferroptosis inhibition by ferrostatin-1, Redox Biol., 28, 101328, 10.1016/j.redox.2019.101328 · DOI · Paper page
  133. Liu, 2015, The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis, Biol. Pharm. Bull., 38, 1234, 10.1248/bpb.b15-00048 · DOI · Paper page
  134. Kajarabille, N., and Latunde-Dada, G.O. (2019). Latunde-Dada Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators. Int. J. Mol. Sci., 20. · DOI · Paper page
  135. Kagan, 2017, Oxidized Arachidonic/Adrenic Phosphatidylethanolamines Navigate Cells to Ferroptosis, Nat. Chem. Biol., 13, 81, 10.1038/nchembio.2238 · DOI · Paper page
  136. Silva, 2004, Reevaluating the role of 1,10-phenanthroline in oxidative reactions involving ferrous ions and DNA damage, Biochim. Biophys. Acta - Gen. Subj., 1675, 46, 10.1016/j.bbagen.2004.08.006 · DOI
  137. Viganor, 2016, The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance, Curr. Top. Med. Chem., 17, 1280, 10.2174/1568026616666161003143333 · DOI
  138. Taher, 2016, Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes, Drug Des. Devel. Ther., 10, 4073, 10.2147/DDDT.S117080 · doi:10.2147/dddt.s117080
  139. Kontoghiorghes, 2019, Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology, Expert Opin. Investig. Drugs, 28, 593, 10.1080/13543784.2019.1631284 · DOI
  140. Hider, 2018, The role of deferiprone in iron chelation, N. Engl. J. Med., 379, 2140, 10.1056/NEJMra1800219 · DOI

Cited by

See all 115

Metadata

Authors
Macías-Rodríguez, R. U., Inzaugarat, M. E., Ruiz-Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-02-28
Volume
21
Issue
5
Pages
1651
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3009904103
Cited by
115
References
48
FWCI
9.11
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death? https://app.cochat.ai/papers/10.3390/ijms21051651
The paper
Macías-Rodríguez, R. U., Inzaugarat, M. E., Ruiz-Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020). Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death? International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21051651

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.